management of diabetic and epileptic patient in dentistry

Upload: abi2189

Post on 03-Apr-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    1/26

    MANAGEMENT OFDIABETIC AND EPILEP

    PATIENT IN DENTISTR

    PRE

    S

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    2/26

    DIABETESMELLITUS

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    3/26

    DEFINITION Diabetes is the most common endocrine disease .It is a group of diseas

    by high levels of blood glucose resulting from defects in insulin produc

    CLASSIFICATION1.TYPE 1- Insulin dependent or juvenile onset. Immune mediated

    Idiopathic

    2. TYPE 2-Non Insulin dependent or adult onset. Genetic defects of beta cell function

    Genetic defects of insulin action Disease of exocrine pancrease Drug chemical induce Infections

    3.GESTATIONAL DIBETES MELLITUS

    4.IMPAIRED GLUCOSE TOLERENCE

    5.IMPAIRED FASTING GLUCOSE

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    4/26

    TYPE 1 DM

    It can occur at any age but is more common among children and young

    The peak age onset is 10 to 14 yrs.

    It is characterized by insulin deficiency.

    In DM circulating insulin is essentially absent.

    TYPE 2 DM

    Non-ketotic form of diabetes that is not linked to humans lymphocyte markers on the 6th chromosomes.

    High incidence of obesity.

    GESTATIONAL DM

    It is characterized by abnormal result on the oral glucose tolerance testduring pregnancy.

    Risk of prenatal illness and death in all levels of disease severity.

    IMPAIRED GLUCOSE TOLERANCE/IMPAIRED FASTING GLUCOSE TOLERA

    Persons with IGT have plasma glucose level between 140 199 mg/dl aoral glucose tolerance test.

    IFGT

    The fasting blood sugar level is 100

    125mg/dl.

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    5/26

    DM RISK FACTORS

    Age above 45 yrs

    BMI

    Habitual physical activity High risk ethinicity

    H/O child weight greater than 9 pounds at birth

    H/O gestational diabetes

    Hypertension

    Triglycerides 250 mg/dl

    Cholestrol 35 mg/dl

    H/O vascular disease

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    6/26

    COMPLICATIONS

    ACUTE COMPLICATIONS

    Hypoglycemia

    Diabetic ketoacidosis

    Hyperglycemia

    CHRONIC COMPLICATIONS

    Microvasculature

    Cardiovascular system- Artherosclerosis,Large vessel disease,Micro

    Eyes

    Retinopathy,Catract , Glaucoma. Kidney- Diabetic glomerulonephritis.

    Nerves- Motor ,sensory , autonomic neuropathy.

    Mouth- Gingivitis, Increased dental caries and Periodontal disease

    Skin- Pruritis, Mycosis, Diabetic xanthoma.

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    7/26

    HYPERGLYCEMIAETIOLOGY

    High blood sugar

    Weight gain

    Cessation of exercise Pregnancy

    Hyperthyroidism

    Corticosteroid theraphy

    Fever

    Acute infection

    SIGNS

    Hyperglycemia

    Acidosis with blood PH- 7.3

    Dry warm skin

    Fruity, sweet breath odour

    Normal to low BP

    Rapid weak pulse

    Altered level of consciousness

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    8/26

    SYMPTOMS

    TYPE 1 DM

    Repeated skin infection

    Marked irritability Headache

    Drowsiness

    Malaise

    Dry mouth

    TYPE 2 DM

    Decresed vision

    Parasthesia

    Loss of sensation

    Postural hypotension

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    9/26

    CLINICAL MANIFESTATIONTYPE 1 TY

    POLYURIA

    +++

    POLYDIPSIA ++ +

    POLYPHAGIA WITH WT LOSS ++ _

    RECURRENT BLURRED VISION + ++

    VULVOVAGINITIS OR PRURITIS + ++

    LOSS OF STRENGTH ++ +

    NOCTURNAL ENURESIS ++ _

    ABSENCE OS AYMPTOMS _ ++

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    10/26

    MANGEMENTRECOGNIZE PROBLEM

    ( Lack of response to sensory stimulation)

    DISCONTINUE DENTAL TREATMENT

    ACTIVE OFFICE EMERGENCY TEAM

    POSITON PATIENT IN SUPINE POSITION WITH FEET ELEVATED

    A-B-C ASSESS AND PERFORM BASIC LIFE SUPPORT AS NEEDED

    D- PROVIDE DEFINITIVE MANAGEMENT AS NEEDED

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    11/26

    HYPOGLYCEMIAETIOLOGY

    Weight loss

    Increased physical exercise

    Termination of pregnancy Termination of other drug therapies

    Recovery from infection and fever

    Inadequate food( Carbohydrate intake)

    Excessive insulin dose

    Sulfonyl urea theraphy

    Ethanol intake

    SIGNS

    Weakness, Dizziness

    Pale moist skin

    Normal or depressed respiration

    Headache

    Altered level of consciousness

    CLINICAL MANIFESTATION

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    12/26

    CLINICAL MANIFESTATIONEARLY STAGE Mild reaction

    Diminished cerebral function

    Changes in mood

    Decreased spontaneity

    Hunger

    Nausea

    MORE SEVERE STAGE

    Sweating

    Tachycardia

    Increased anxiety

    Belligerence

    Poor judgement

    Uncoporativeness

    LATER SEVERE STAGE

    Unconsciousness

    Seizure activity

    Hypotenion

    Hypothermia

    MANGEMENT

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    13/26

    MANGEMENTRECOGNIZE THE PROBLEM

    ( Altered consciousness)

    DISCONTINUE DENTAL TREATMENT

    ACTIVE OFFICE EMERGENCY TEAM

    P- POSITION PATIENT COMFORTABLY

    A-B-C ASSESS AND PERFORM BASIC LIFE SUPPORT AS NEDDED

    D- PROVIDE DEFINITIVE MANAGEMENT

    ADMINISTER ORAL CARBOHYDRATES

    IF SUCCESSFUL IF UNSUCCESSFUL

    Permit PT to recover Activate emergency medical services

    Discharge PT Administer parentral carbohydrates

    Monitor PTDischarge the PT

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    14/26

    DIABETIC KETOACIDOSIS:

    Diabetic ketoacidosis (DKA) is a potentially life-threatening complication in patients withmellitus. It happens predominantly in those with type 1 diabetes, but it can occur in those with tyunder certain circumstances. DKA results from a shortage of insulin; in response the body switchefatty acids and producing acidic ketone bodies that cause most of the symptoms and complicatio

    Signs and symptoms

    Predominant symptoms are nausea and vomiting, pronounced thirst, excessive urine producabdominal pain that may be severe.

    Coffee ground vomiting (vomiting of altered blood) occurs in a minority of patients; this tenfrom erosion of the esophagus.[3] In severe DKA, there may be confusion, lethargy, stupor or evemarked decrease in the level of consciousness).

    MANAGEMENT:

    1 Fluid replacement

    2 Insulin

    3 Potassium

    4 Bicarbonate

    5 Cerebral edema

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    15/26

    MANAGEMENT BY DRUGS

    Metfromin

    Rosiglitazone

    Glipizide

    Acarbose

    Repaglinide

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    16/26

    EPILEPSY

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    17/26

    DEFINITIONRECURRENT PAROXYSMAL DISORDER OF CEREBRAL FUNCTION MARKEDSUDDEN , BRIEF ATTACKS OF ALTERED CONSCIOUSNESS MOTOR ACTIVITSENSORY PHENOMENA.

    CAUSES

    Congenital abnormalities

    Perinatal injuries

    Metabolic and toxic disorders

    Head trauma

    Tumors and other space occupying lesions

    Vascular disease

    Infectious disease

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    18/26

    ABSENCE SEIZURE & PARTIALSEIZUREDIAGNOSTIC CLUES FOR THE PRESENCE OF SEIZURE:

    Sudden onset of immobility & blank stare

    Simple automatic behaviour

    Slow blinking eyelids

    Short duration

    Rapid recovery

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    19/26

    MANAGEMENT

    RECOGNIZE PROBLEM

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    20/26

    RECOGNIZE PROBLEM

    ( Lack of response to sensory stimulation)

    DISCONTINUE THE DENTAL TREATMENT

    ACTIVE OFFICE EMERGENCY TEAM AS NEDDED

    POSITION THE PT IN SUPINE POSITION WITH FEET ELEVATED

    Seizure Ceases reassure Pt Seizure continues( 75

    active emergency me

    Allow Pt to recover before discharge A-B-C Perform basic l

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    21/26

    TONIC CLONIC SEIZURE( GRANMAL)

    DIAGNOSTIC CLUES: Presence of aura prior to loss of consciousness

    Tonic- clonic muscle contraction

    Clenched teeth, tongue biting

    PREMODAL PHASE

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    22/26

    RECOGNIZE AURA

    DISCONTINUE DENTAL TREATMENT

    ICTAL PHASE

    ACTIVATE OFFICE EMERGENCY TEAM

    P-POSITION PATIENT IN SUPINE POSTION WITH FEET ELEVATED

    CONSIDER ACTIVATION OF EMERGENCY MEDICAL SERVICES

    A-B-C ASSESS & PERFORM BASIC LIFE SUPPORT AS NEEDED

    DEFINITE CARE ADMINISTER O2 MONITOR VITAL SIGNS

    REASSURE PT AND PERMIT RECOVERY DISCHARGE PT

    TO HOPITAL TO HOME TO PHYSICIAN

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    23/26

    TONIC-CLONIC STATUS MANAGEM

    PREMODAL PHASE

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    24/26

    RECOGNIZE AURA

    DISCONTINUE DENTAL TREATMENT

    ICTAL PHASE

    ACTIVATE OFFICE EMERGENCY TEAM

    P-POSITION PATIENT IN SUPINE POSTION WITH FEET ELEVATED

    CONSIDER ACTIVATION OF EMERGENCY MEDICAL SERVICES

    A-B-C ASSESS & PERFORM BASIC LIFE SUPPORT AS NEEDED

    DEFINITE CARE

    PROTECT PT FROM INJURY

    IF SEIZURE PERSISTS FOR MORE THAN 15 MINS

    A-B-C PERFORM VENIPUNCTURE &ANTICONVULSANT

    DEFINITIVE CARE PROTECT PT ADMINISTER 50% IV DEXTRO

    FROM INJURY UNTIL EMERGENCY

    ASSISTANCE ARRIVES

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    25/26

    MANAGEMENT OF EPILEPSY BY

    DRUGS Carbamazepine 15-25 mg/kg

    Phenytoin 3-8 mg/kg

    Phenobarbitol 2-4 mg/kg

    Primidone 10-20 mg/kg

    Ethosuximide 10-30 mg/kg

    Clonazepam 0.03-0.3 mg/kg

    Valporate 15-60 mg/kg

    NEW DRUGS Oxcarbazepine

    Felbamate

    Tiagabine

  • 7/28/2019 Management of Diabetic and Epileptic Patient in Dentistry

    26/26